Medication info
Samik Hydrochloride Metformin Tablets (Metformin Hydrochloride)

Samik Hydrochloride Metformin Tablets (Metformin Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
(Samik Pharmaceutical Co., Ltd.)
Appearance
This medicine is a white, round, film-coated tablet.
Packaging
30 tablets/bottle, 500 tablets/bottle
Approval status
Active

MFDS item code 199803425 · Notified 1998.07.30 · Insurance code 644000800

Summary

Main use
Treatment of type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
The dosage should be determined individually based on the drug's efficacy and tolerability, and should not exceed the recommended maximum daily dose. Treatment with this drug must be initiated at a low dose to reduce gastrointestinal adverse reactions and to identify the minimum dose required for adequate glycemic control. Administer 500mg 2~3 times daily with meals. Increase the dose gradually by 500mg each week. When administering up to 2000mg, the dose is usually divided into 2 doses, in the morning and evening. If the dose exceeds 2000mg, divide it into 3 doses daily and administer with meals; the maximum daily dose is 2550mg. During treatment initiation and dose adjustment, measure fasting blood glucose to assess the response to this drug and identify the minimum effective dose. Measure blood glycated hemoglobin levels at approximately 3-month intervals. The goal of treatment with this drug, whether administered as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood glycated hemoglobin levels to normal or near-normal levels using the minimum effective dose. In general, when blood glucose is temporarily uncontrolled in patients whose levels were controlled with diet alone, short-term administration of this drug may be sufficient to achieve an adequate effect. This drug may be used in patients with moderate renal impairment at stage 3a (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who have no other condition that may increase the risk of lactic acidosis, with the following dosage adjustments. - The initial dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, administered in 2 divided doses. Renal function should be monitored closely every 3-6 months. If creatinine clearance or glomerular filtration rate falls below 45ml/min or 45ml/min/1.73㎡, respectively, this drug must be discontinued immediately.
Child dose
Children aged 10 years and older or adolescents who are still growing: The usual initial dose is 500 milligrams once daily, taken during or after a meal. Measure blood glucose after one week and adjust the dose. Gastrointestinal adverse effects may improve with gradual dose increases. The maximum daily dose is 2000mg. Divide this dose into 2~3 administrations.

Ingredients

Manufacturer
(Samik Pharmaceutical Co., Ltd.)

Efficacy & effects

Treatment of type 2 diabetes mellitus

  • Type 2 diabetes
View approved original text

This medication is used for the treatment of patients with type 2 diabetes who have inadequate blood glucose control with diet and exercise alone, especially in overweight patients. In adults, this medication can be administered alone or in combination with other oral hypoglycemic agents or insulin. It can also be safely administered to children aged 10 years and above and growing adolescents either as monotherapy or in combination with insulin. This medication effectively aids in blood glucose control and improves diabetes management.

How to take

Adult dose

The dosage should be determined individually based on the drug's efficacy and tolerability, and should not exceed the recommended maximum daily dose. Treatment with this drug must be initiated at a low dose to reduce gastrointestinal adverse reactions and to identify the minimum dose required for adequate glycemic control. Administer 500mg 2~3 times daily with meals. Increase the dose gradually by 500mg each week. When administering up to 2000mg, the dose is usually divided into 2 doses, in the morning and evening. If the dose exceeds 2000mg, divide it into 3 doses daily and administer with meals; the maximum daily dose is 2550mg. During treatment initiation and dose adjustment, measure fasting blood glucose to assess the response to this drug and identify the minimum effective dose. Measure blood glycated hemoglobin levels at approximately 3-month intervals. The goal of treatment with this drug, whether administered as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood glycated hemoglobin levels to normal or near-normal levels using the minimum effective dose. In general, when blood glucose is temporarily uncontrolled in patients whose levels were controlled with diet alone, short-term administration of this drug may be sufficient to achieve an adequate effect. This drug may be used in patients with moderate renal impairment at stage 3a (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who have no other condition that may increase the risk of lactic acidosis, with the following dosage adjustments. - The initial dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, administered in 2 divided doses. Renal function should be monitored closely every 3-6 months. If creatinine clearance or glomerular filtration rate falls below 45ml/min or 45ml/min/1.73㎡, respectively, this drug must be discontinued immediately.

Child dose

Children aged 10 years and older or adolescents who are still growing: The usual initial dose is 500 milligrams once daily, taken during or after a meal. Measure blood glucose after one week and adjust the dose. Gastrointestinal adverse effects may improve with gradual dose increases. The maximum daily dose is 2000mg. Divide this dose into 2~3 administrations.

Precautions

This medication may cause severe lactic acidosis or hypoglycemia, hence it must not be administered particularly to patients with moderate to severe renal impairment or acute cardiac and renal disorders. This medication must be stopped before examinations using iodinated contrast agents and can only be resumed after confirming normal kidney function post-examination. Patients who have had allergic reactions to this medication or similar drugs in the past, type 1 diabetes patients, and those with acute or chronic metabolic acidosis should not receive this medication. Patients with severe infections or serious trauma, before and after surgery, in malnourished states, with liver dysfunction, severe pulmonary dysfunction, or excessive alcohol intake should temporarily discontinue or use this medication with extreme caution. Renal function should be regularly monitored while taking this medication, and it should be immediately discontinued if there is a rapid decline in kidney function or signs of dehydration. Gastrointestinal symptoms (such as diarrhea, nausea, vomiting, etc.) may occur, which are usually transient but may necessitate dosage adjustments or discontinuation in severe cases. This medication can occasionally cause a metallic taste or skin rashes, anemia, vitamin B12 deficiency, abnormal liver functions, and in rare cases, hypoglycemia. Patients should consult a doctor when experiencing unusual symptoms. Care should be taken with vigorous exercise or irregular meals, as there is a risk of lactic acidosis and hypoglycemia when taking other interacting medications. Alcohol can increase the risk of side effects associated with this medication, so excessive drinking should be avoided while on this medication. During pregnancy, it should be used with careful monitoring of the fetal and maternal condition, and during breastfeeding, careful consideration should be given to whether to continue breastfeeding or to discontinue drug therapy, as this medication can be secreted in breast milk. Elderly patients are at increased risk for renal impairment; therefore, dosage adjustments and regular renal function monitoring are necessary. This medication can interact with several other medications. If taking other medications, be sure to inform healthcare providers and carefully monitor blood glucose and physical condition. In cases of overdose, blood dialysis can be used to remove the drug, so if an overdose is suspected, immediate medical attention is required. This medication does not cause weight gain and helps achieve stable blood glucose control and reduce the risk of diabetes complications with long-term use. This medication should be stored out of reach of children and should not be transferred to other containers.

Side effects

  • Lactic acidosis
  • diarrhea
  • nausea
  • vomiting
  • abdominal distension
  • loss of appetite
  • dyspepsia
  • constipation
  • abdominal pain
  • metallic taste
Show 7 more
  • rash
  • anemia
  • leukopenia
  • thrombocytopenia
  • vitamin B12 deficiency
  • liver dysfunction
  • severe delayed hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is also best stored in a cool, dry place away from direct sunlight.

Appearance and packaging

Appearance

This medicine is a white, round, film-coated tablet.

Package unit

30 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.